NMDA-IN-1

CAS No. 700878-19-9

NMDA-IN-1( —— )

Catalog No. M26334 CAS No. 700878-19-9

NMDA-IN-1 is a potent and NR2B-selective antagonist of NMDA(NMDA Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 205 Get Quote
10MG 357 Get Quote
25MG 587 Get Quote
50MG 822 Get Quote
100MG 1107 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NMDA-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    NMDA-IN-1 is a potent and NR2B-selective antagonist of NMDA(NMDA Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM).
  • Description
    NMDA-IN-1 is a potent and NR2B-selective antagonist of NMDA(NMDA Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    NMDAR
  • Recptor
    PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    700878-19-9
  • Formula Weight
    375.87
  • Molecular Formula
    C20H23ClFN3O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 12.5 mg/mL (33.26 mM)
  • SMILES
    Cl.Oc1ccc2nc(CN3CCC(Cc4ccccc4F)CC3)[nH]c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
  • CIQ

    CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit. EC50 value: 2.7 μM for NR2C and 2.8 μM for NR2D.

  • R-(+)-EU-1180-453

    R-(+)-EU-1180-453 is a novel GluN2C/D selective NMDAR-positive modulator for the study of neurological disorders.

  • Selfotel

    CGS 19755 is a selective, competitive NMDA antagonist that inhibits [3H]-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid binding to NMDA-type receptors with IC50 of 50 nM.